The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective

Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease remain. Alemtuzumab (Lemtrada®) is a highly effica...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Neurol Disord
Main Authors: Alroughani, Raed, Van Wijmeersch, Bart, Al Khaboori, Jabber, Alsharoqi, Isa Ahmed, Ahmed, Samar F., Hassan, Ali, Inshasi, Jihad, Krieger, Derk W., Shakra, Mustafa, Shatila, Ahmed Osman, Szolics, Miklos, Khallaf, Mohamed, Ezzat, Aly
Format: Artigo
Language:Inglês
Published: SAGE Publications 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498833/
https://ncbi.nlm.nih.gov/pubmed/32973927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420954119
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items